Surgical resection of malignant brain tumors with stereotaxic guidance

Authors

  • Sergio A. Sacchettoni “Vargas” Hospital, Caracas. Venezuela

DOI:

https://doi.org/10.47924/neurotarget2007363

Keywords:

stereotaxis, gliomas, surgical technique, neuronavigation

Abstract

The authors reports a Phase I clinic study of a surgical technique for resecting glial tumors located in or near cerebral motor structures (motor cortical area or internal capsule). Gliomas resection in this location always carries a significant risk of injury of motor function. To reduce this kind of risk, it has been advocated the use of computer-assisted stereotactic volumetric approach (neuronavigation), intraoperative ultrasonography, intraoperative magnetic resonance (MR) or intraoperative cortical recording. However, this technological devices are costly or requires special expertise to be applied adequately and massively. In order to find a simpler manner to resect imagenologically defined tumors, the author performed guided resection of tumors by stereotactically placing cotton marks embebbed in trypan blue. The first mark is placed at the volumetric center of the tumor and/or at its bottom; other 3 to 4 marks are placed at the borders, adjacent to the motor structure to be spared. Once the marks are placed, craniotomy is performed followed by a corticotomy as conventionally. The approach is continued by following the cord of the mark placed in the center or at the bottom. Once the tumor is reached, resection is done as usual, stopping every time an edge/border mark is encountered. Edges where no mark has been placed, the end of the resection will depend upon surgeon’s own criterion. This series include 12 cases operated on for gliomas of variable grade, located adjacent to the motor area or to the internal capsule. Motor function and life quality were clinically assesed, using the motor scale (muscle strentgth grade) and quality of life using the Karnofsky’s scale, respectively. Anatomically, tumor resection was assesed comparing pre and post operative MR. Gross-total resection was accomplished in all cases. In 2 out of a total of 12 patients motor function worsened temporarily, and 4 patients diminished grading in the Karnofsky’s scale (including 2 first patients). The authors conclude that this modality for stereotactic navigation is feasible to be continued at a Phase II study, in view that, in this series, surgical resection was totally achieved without major morbidity.

Metrics

Metrics Loading ...

References

Santos, S. Epidemiología del Cáncer Pediátrico. En: Libro de Ponencias: L Congreso Nacional de Pediatría “Dr. Francisco Finizola Celli”. Villa Bellas Artes, Barquisimeto - Estado Lara; 28 de agosto - 3 de septiembre de 2004. Caracas: Sociedad Venezolana de Puericultura y Pediatría. Archivos Venezolanos de Puericultura y Pediatría; 2004. p. 13-6.

Ministerio de Salud y Desarrollo Social de la República Bolivariana de Venezuela – MSDS. Anuario de Mortalidad 2000. Caracas: MSDS; 2001.

Sacchettoni SA, García Y, Teneud L, Onay D, Rada P, Galera R, et al. Neuroimplante, terapia genética y microdiálisis cerebral en enfermedad de Parkinson [resumen]. Act Cient Ven 2000;51(1 Supl 1):143.

Del Corral JF, Hernández L, Sacchettoni SA, García Y, Onay D, Teneud L, et al. Microdiálisis cerebral en humanos: experiencia en la enfermedad de Parkinson. Arch Hosp Vargas 2000;42(2):93-6.

Rada P, Tucci S, Teneud L, Paez X, Perez J, Alba G, et al. Monitoring gammaaminobutyric acid in human brain and plasma microdialysates using micellar electrokinetic chromatography and laser-induced fluorescence detection. J Chromatogr B Biomed Sci Appl 1999;735(1):1-10.

Ali S, King GD, Curtin JF, Candolfi M, Xiong W, Liu C, et al. Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model. Cancer Res 2005;65(16):7194-204.

Gomez GG, Kruse CA. Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther Mol Biol 2006;10(a):133-146.

Gómez GG, Varella-Garcia M, Kruse CA. Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization. Cancer Genet Cytogenet 2006;165(2):121-34.

Goverdhana S, Puntel M, Xiong W, Zirger JM, Barcia C, Curtin JF, et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther 2005;12(2):189-211.

Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005;7(1):7-16.

King GD, Curtin JF, Candolfi M, Kroeger K, Lowenstein PR, Castro MG. Gene therapy and targeted toxins for glioma. Curr Gene Ther 2005;5(6):535- 57.

Cavaliere R, Lopes MB, Schiff D. Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 2005;4(11):760-70.

Neyns B, Sadones J, Chaskis C, De Ridder M, Keyaerts M, Veld PI, et al. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature. Acta Neurol Belg 2005;105(3):137-43.

Newton HB. Intraarterial chemotherapy of primary brain tumors. Curr Treat Options Oncol 2005;6(6):519-30.

Paleologos NA. Chemotherapy for low-grade gliomas. Expert Rev Neurother 2005;5(6 Suppl):S21-4.

van den Bent MJ, Hegi ME, Stupp R. Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 2006;42(5):582-8.

Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 2005;63(3):655-66.

Hafez RF. Stereotaxic gamma knife surgery in treatment of critically located pilocytic astrocytoma: preliminary result. World J Surg Oncol 2007;5:39.

Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, et al. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 2005;61(2):374-9.

Mehta N, Silverberg W. Role of radiotherapy in the treatment of gliomas. Expert Rev Neurother 2005;5(6 Suppl):S51-61.

Ozyigit G, Onal C, Gurkaynak M, Soylemezoglu F, Zorlu F. Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients. J Neurooncol 2005;75(2):189-93.

Bernstein M, Gutin PH. Interstitial irradiation of brain tumors: a review. Neurosurgery 1981;9(6):741-50.

Corrêa CF. Radioterapia intersticial para o tratamento dos tumores encefálicos. Tese apresentada a Universidade Federal de São Paulo, Escola Paulista de Medicina para obtenção do grau de Doctor. São Paulo; 1999. p. 143.

Kreth FW, Faist M, Warnke PC, Rossner R, Volk B, Ostertag CB. Interstitial radiosurgery of low-grade gliomas. J Neurosurg 1995;82(3):418-29.

Vitaz TW, Warnke PC, Tabar V, Gutin PH. Brachytherapy for brain tumors. J Neurooncol 2005 May;73(1):71-86.

Litofsky NS, Bauer AM, Kasper RS, Sullivan CM, Dabbous OH; Glioma Outcomes Project Investigators. Image-guided resection of high-grade glioma: patient selection factors and outcome. Neurosurg Focus 2006;20(4):E16.

Peraud A, Goetz C, Siefert A, Tonn JC, Kreth FW. Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study. Childs Nerv Syst 2007;23(1):39-46.

Black KL, Ciacci JR. The limits of treatment of malignant gliomas. West J Med 1993;158(1):65-6.

Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg 2004;100(1):41-6.

Mariani L, Siegenthaler P, Guzman R, Friedrich D, Fathi AR, Ozdoba C, et al. The impact of tumour volume and surgery on the outcome of adults with supratentorial WHO grade II astrocytomas and oligoastrocytomas. Acta Neurochir (Wien) 2004;146(5):441-8.

Russell SM, Kelly PJ. Incidence and clinical evolution of postoperative deficits after volumetric stereotactic resection of glial neoplasms involving the supplementary motor area. Neurosurgery 2003;52(3):506-16.

Talos IF, Zou KH, Ohno-Machado L, Bhagwat JG, Kikinis R, Black PM, et al. Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 2006;239(2):506-13.

Dorward NL, Alberti O, Velani B, Gerritsen FA, Harkness WF, Kitchen ND, et al. Postimaging brain distortion: magnitude, correlates, and impact on neuronavigation. J Neurosurg 1998;88(4):656-62.

Alshail E, Rutka JT, Drake JM, Hoffman HJ, Humphreys R, Phillips J, et al. Utility of frameless stereotaxy in the resection of skull base and Basal cerebral lesions in children. Skull Base Surg 1998;8(1):29-38.

Golfinos JG, Fitzpatrick BC, Smith LR, Spetzler RF. Clinical use of a frameless stereotactic arm: results of 325 cases. J Neurosurg 1995;83(2):197-205.

Jolesz FA, Kikinis R, Talos IF. Neuronavigation in interventional MR imaging. Frameless stereotaxy. Neuroimaging Clin N Am 2001;11(4):685-93, ix.

Samset E, Høgetveit JO, Cate GT, Hirschberg H. Integrated neuronavigation system with intraoperative image updating. Minim Invasive Neurosurg 2005;48(2):73-6.

Alterman RL, Kall B, Beric A, Sterio D, Kelly PJ. Pallidal targeting with the COMPASS system. Stereotact Funct Neurosurg 1997;69(1-4 Pt 2):69-72.

Kelly PJ. Stereotactic surgery: What is past is prologue. Neurosurgery 2000;46(1):16-27.

Morita A, Kelly PJ. Resection of intraventricular tumors via a computer assisted volumetric stereotactic approach. Neurosurgery 1993;32(6):920-6.

Ammirati M, Gross JD, Ammirati G, Dugan S. Comparison of registration accuracy of skin and bone implanted fiducials for frameless stereotaxis of the brain: a prospective study. Skull Base 2002;12(3):125-30.

Kanno H, Ozawa Y, Sakata K, Sato H, Tanabe Y, Shimizu N, et al. Intraoperative power Doppler ultrasonography with a contrast-enhancing agent for intracranial tumors. J Neurosurg 2005;102(2):295-301.

Shinoura N, Takahashi M, Yamada R. Delineation of brain tumor margins using intraoperative sononavigation: implications for tumor resection. J Clin Ultrasound 2006;34(4):177-83.

Sacchettoni SA, Merchán B, Rojas MM, Galera R, Del Corral JF. Abordaje estereotáxico para resección de gliomas. En: Libro de Ponencias: XXIV Con- greso Latinoamericano de Neurocirugía. Miami, USA; marzo de 1991.

Published

2007-11-01

How to Cite

1.
Sacchettoni SA. Surgical resection of malignant brain tumors with stereotaxic guidance. NeuroTarget [Internet]. 2007 Nov. 1 [cited 2024 Nov. 21];2(3):16-23. Available from: https://neurotarget.com/index.php/nt/article/view/363